Adding CAR T-Cell Therapy to the Electronic Medical Record

Video

Andrea Price, APN, discusses adding CAR T-cell therapy to the electronic medical record.

Andrea Price, APN, associate director for clinical research at Washington University School of Medicine, discusses adding CAR T-cell therapy to the electronic medical record (EMR).

While CAR T-cell therapy is not new to providers, the therapy is not yet integrated into the EMR system, explains Price. Adding CAR T-cell therapy to the EMRs requires a lot of collaboration with the EMR team to make sure it fits the workflows and special patient populations. These tools need to be designed from scratch, according to Price.

The priority regarding CAR T-cell therapy in EMR is creating nursing documentation for specialized orders for patients, says Price. Further implementation will require best practice advisories. The EMR has triggers that recognize patient traits to help providers drive decision making, which is the next step of adding CAR T-cell therapy to EMR. The challenge is avoiding overnotifying the providers or nurses and, instead, drilling down the specific patients within the EMR that need to be worked on, concludes Price.

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Derek Jackson, BS, MA, the vice president of cell & gene therapy product development at Pacira, and Kilian Guse, PhD, the vice president of genetic medicine platforms at Pacira
Derek Jackson, BS, MA, the vice president of cell & gene therapy product development at Pacira
Jeffrey Chamberlain, PhD
Tami John, MD
Tami John, MD
Tami John, MD
Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital
Saurabh Dahiya, MD, FACP, an associate professor of medicine at Stanford University School of Medicine; as well as clinical director of Cancer Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy at Stanford Medicine
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Related Content
© 2025 MJH Life Sciences

All rights reserved.